Suchergebnisse - "Lie, Albert Kwok-Wai"

PubPharm (13)

1

Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19 : an open-label, randomised, phase 2 trial

enthalten in: Lancet (London, England) | 2020

von Hung, I. | Lung, K. | Tso, E. | +41

CommentIn: Lancet. 2020 May 30;395(10238):1670-1671. - PMID 32401712

2

Advances in hematopoietic stem cell transplantation in the Asia-Pacific region : the second report from APBMT 2005-2015

enthalten in: Bone marrow transplantation | 2019

von Iida, M. | Kodera, Y. | Dodds, A. | +19

ErratumIn: Bone Marrow Transplant. 2023 Apr;58(4):469. - PMID 36596883

3

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies : a phase 3, randomised, clinical trial and post-hoc efficacy analysis

enthalten in: The Lancet. Infectious diseases | 2019

von Dagnew, A. | Ilhan, O. | Lee, W. | +77

CommentIn: Lancet Infect Dis. 2019 Sep;19(9):922-924. - PMID 31399376

4

Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation : A Randomized Clinical Trial

enthalten in: JAMA | 2019

von Bastidas, A. | de la Serna, J. | El Idrissi, M. | +128

ErratumIn: JAMA. 2019 Aug 27;322(8):785. - PMID 31454023

5

LDH is an adverse prognostic factor independent of ISS in transplant-eligible myeloma patients receiving bortezomib-based induction regimens

enthalten in: European journal of haematology | 2015

von Chim, C. | Sim, J. | Tam, S. | +3

6

LDH is an adverse prognostic factor independent of ISS in transplant‐eligible myeloma patients receiving bortezomib‐based induction regimens

enthalten in: European journal of haematology | 2015

von Chim, C. | Sim, J. | Tam, S. | +3

7

Unsustained complete response of less than 24 months after autologous stem cell transplantation predicts aggressive myeloma with short survival

enthalten in: Hematological oncology | 2014

von Chim, C. | Liu, H. | Lie, A. | +4

8

Treatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTD

enthalten in: Journal of hematology & oncology | 2012

von Chim, C. | Lie, A. | Chan, E. | +10

9

Treatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTD

enthalten in: Journal of hematology & oncology | 2012

von Chim, C. | Lie, A. | Chan, E. | +9

10

Determinants of peripheral blood count value in long-term survivors of allogeneic hemopoietic stem cell transplantation

enthalten in: Hematological oncology | 2009

von Koljonen, P. | Lie, A. | Liang, R. | +1